tiprankstipranks
Esperion (ESPR)
NASDAQ:ESPR
US Market
ESPR
Esperion
RESEARCH TOOLSreports

Esperion (ESPR) Stock News & Sentiment

1,658 Followers
Esperion Completes Corstasis Acquisition, Expands Cardiovascular Portfolio
Premium
Company Announcements
Esperion Completes Corstasis Acquisition, Expands Cardiovascular Portfolio
10d ago
8K
ESPR
Esperion Therapeutics Earnings Call Signals Expansion
Premium
Company Announcements
Esperion Therapeutics Earnings Call Signals Expansion
11d ago
ESPR
Esperion Therapeutics: CLEAR Outcomes Stroke Data and Commercial Momentum Underscore Buy-Rated Cardiovascular Franchise
Premium
Ratings
Esperion Therapeutics: CLEAR Outcomes Stroke Data and Commercial Momentum Underscore Buy-Rated Cardiovascular Franchise
13d ago
ESPR
Esperion Therapeutics Flags Material Weakness in Financial Controls, Raising Reporting and Regulatory Risks
Premium
Company Announcements
Esperion Therapeutics Flags Material Weakness in Financial Controls, Raising Reporting and Regulatory Risks
1M ago
ESPR
Esperion Therapeutics: Strong 2025 Execution, Expanding Cardiometabolic Platform, and Vision 2040 Underpin Buy Rating
Premium
Ratings
Esperion Therapeutics: Strong 2025 Execution, Expanding Cardiometabolic Platform, and Vision 2040 Underpin Buy Rating
1M ago
ESPR
Options Volatility and Implied Earnings Moves Today, March 10, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves Today, March 10, 2026
1M ago
FNV
KSS
Balanced Risk-Reward Keeps Esperion at Hold Amid Complex Corstasis Acquisition and CHF Market Challenges
Premium
Ratings
Balanced Risk-Reward Keeps Esperion at Hold Amid Complex Corstasis Acquisition and CHF Market Challenges
1M ago
ESPR
More ESPR News >

ESPR News on the Web

Esperion Therapeutics (ESPR) Down 10% Since Last Earnings Report: Can It Rebound?
Zacks
Neutral
Analysts Offer Insights on Healthcare Companies: Esperion (ESPR), PROCEPT BioRobotics (PRCT) and Vericel (VCEL)
TipRanks News
Bullish
Esperion Completes Corstasis Acquisition, Expands Cardiovascular Portfolio
TipRanks News
Neutral
Esperion, Athyrium Capital enter $50M royalty financing agreement
TipRanks News
Bullish
Esperion Therapeutics Earnings Call Signals Expansion
TipRanks News
Bullish
Esperion Therapeutics: CLEAR Outcomes Stroke Data and Commercial Momentum Underscore Buy-Rated Cardiovascular Franchise
TipRanks News
Bullish
Analysts Have Conflicting Sentiments on These Healthcare Companies: Passage Bio (PASG), Phreesia (PHR) and Esperion (ESPR)
TipRanks News
Bearish
Esperion showcases new data from CLEAR Outcomes trial
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
ESPR
Sector Average
Media Buzz
This Week1 articles
Weekly Average3.5 articles
News Sentiment
This Week50%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ESPR’s Media Buzz Sentiment?
1 articles about ESPR were published this week. In an average week, 3.5 articles are published.
    What is ESPR’s weekly average amount of articles?
    In an average week, 3.5 articles about ESPR are published.
      What is ESPR’s News Sentiment?
      50% of articles about ESPR were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        NBIXNeurocrine
        STAAStaar Surgical
        SLPSimulations Plus
        OWLTOwlet
        Showing the stocks with the most bullish news sentiment over the past week